Kidney Health Initiative (KHI)

Advancing the Therapeutic Pipeline in Alport Syndrome
2026-03-23 16:00 - 17:00 UTC | DC
Join the Kidney Health Initiative (KHI) for a mixer focused on the future of Alport syndrome therapies. Alport Syndrome Foundation will share updates from their December 2025 FDA campus meeting focused on ASSENT (Alport Syndrome Surrogate Endpoint Network), an international initiative with the goal of identifying surrogate endpoints that can be used in clinical trials to accelerate drug development and bring new therapies to patients with Alport syndrome. This session will highlight the status of the pharmaceutical pipeline in Alport syndrome, key challenges and opportunities in drug development for this rare genetic kidney disease, and how this patient organization is partnering with industry at every stage—from preclinical exploration to clinical trial design and patient recruitment. Don’t miss this opportunity to hear the latest insights and connect with others committed to accelerating treatments for the Alport community.

Kidney Innovation Conference
2026-05-20 - 2026-05-21 | Grand Hyatt Washington DC, 1000 H Street NW, Washington, DC, DC, 20001, United States
This annual meeting brings together innovators, patients, care partners, industry, policymakers, and entrepreneurs from across the kidney community. The 2026 agenda will feature:

Dynamic networking sessions designed to foster meaningful connections
In-depth workshops that dive deeper into critical challenges facing the kidney community
Engaging panels and sessions highlighting cutting-edge innovation
Keynote remarks from leading innovators in space

More details including the full agenda and registration information will be shared soon.
